| Stem Cell Therapy as Adjunct to Revascularization (NCT00463853) | US Department of Veterans Affairs | 2007-08-01 |
| Phase I Trial of PX-478 (NCT00522652) | Cascadian Therapeutics Inc. | 2007-08-01 |
| Thai Prophylactic HIV Vaccine Phase I Study (NCT00333424) | Kirby Institute | 2007-08-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Transdermal Electroacupuncture for Opioid Detoxification (NCT00742170) | Mclean Hospital | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Doxercalciferol in Recurrent Pediatric Solid Tumors (NCT00511017) | M.D. Anderson Cancer Center | 2007-08-01 |
| A Possible Therapeutic Role for Adenosine During Inflammation (NCT00513110) | Radboud University Medical Center | 2007-08-01 |
| A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. (NCT00677105) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-08-01 |
| Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine (NCT00520104) | Javelin Pharmaceuticals | 2007-08-01 |
| Behavioral and Physiological Effects of Visual Training (NCT00526942) | Posit Science Corporation | 2007-08-01 |
| Vescell(TM) for the Treatment of Patients With Severe Anginal Syndrome With or Without Heart Failure (NCT00416663) | TheraVitae Ltd. | 2007-08-01 |
| Ursodiol in Huntington's Disease (NCT00514774) | Oregon Health and Science University | 2007-08-01 |
| Safety and Efficacy of an Antioxidant-rich Multivitamin Supplement in Cystic Fibrosis (NCT01018303) | University of Colorado, Denver | 2007-08-01 |
| Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults (NCT00472719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-01 |
| Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects (NCT00605046) | Institute for Neurodegenerative Disorders | 2007-08-01 |
| Ultra-Low Dose Interleukin-2 for Refractory Chronic Graft Versus Host Disease (NCT00529035) | Dana-Farber Cancer Institute | 2007-08-01 |
| Buprenorphine 8 mg Sublingual Tablets Under Fasting Conditions (NCT01157169) | Teva Pharmaceuticals USA | 2007-08-01 |
| Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500 (NCT00518492) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-08-01 |
| A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) (NCT00587015) | MedImmune LLC | 2007-08-01 |
| Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 (NCT00544804) | University of California, San Francisco | 2007-08-01 |
| Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors (NCT00521144) | National Cancer Institute (NCI) | 2007-08-01 |
| A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (NCT00500058) | GlaxoSmithKline | 2007-07-31 |
| Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate (NCT00551564) | GlaxoSmithKline | 2007-07-31 |
| Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults (NCT00510874) | GlaxoSmithKline | 2007-07-28 |
| Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy Participants (NCT00819468) | Shire | 2007-07-26 |
| A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00481091) | AbbVie | 2007-07-25 |
| Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma (NCT00372905) | Northwestern University | 2007-07-24 |
| The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects (NCT00511823) | GlaxoSmithKline | 2007-07-23 |
| T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer (NCT00602693) | Masonic Cancer Center, University of Minnesota | 2007-07-23 |
| A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer (NCT00510718) | Pfizer | 2007-07-23 |
| Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer (NCT00514046) | National Cancer Institute (NCI) | 2007-07-20 |
| Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 (NCT00478725) | GlaxoSmithKline | 2007-07-18 |
| Treatment Strategies for Children With Smith-Magenis Syndrome (NCT00506259) | National Human Genome Research Institute (NHGRI) | 2007-07-17 |
| Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer (NCT00540943) | GlaxoSmithKline | 2007-07-13 |
| Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061) (NCT00511108) | Merck Sharp & Dohme LLC | 2007-07-11 |
| Study of Intermittent OSI-906 Dosing (NCT00514306) | Astellas Pharma Inc | 2007-07-05 |
| GSP as an Novel Indicator for Residual Liver Function in Patients With Fatty Liver (NCT04546022) | National Defense Medical Center, Taiwan | 2007-07-05 |
| A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers (NCT00502346) | Prism Pharmaceuticals | 2007-07-03 |
| Cord Blood Expansion on Mesenchymal Stem Cells (NCT00498316) | M.D. Anderson Cancer Center | 2007-07-03 |
| Bioequivalence and Food Effect Study in Healthy Volunteers (NCT00495274) | GlaxoSmithKline | 2007-07-02 |
| MK0524B Bioequivalence Study (0524B-070) (NCT00943124) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695) (NCT01081158) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age (NCT00493285) | MedImmune LLC | 2007-07-01 |
| Safety and Tolerability of Multiple Inhaled NVA237 Doses in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00545311) | Novartis | 2007-07-01 |
| A Study To Evaluate The Effects Of Repeat Dosing Of Esomeprazole On The Pharmacokinetics Of SB-751689 In Healthy People (NCT00508534) | GlaxoSmithKline | 2007-07-01 |
| An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006) (NCT00511472) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Dynamic Substrate Mapping (DSM) for Ischemic VT (NCT00558857) | Abbott Medical Devices | 2007-07-01 |
| Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult Subjects (NCT00499538) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-07-01 |
| Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies (NCT00629473) | Celgene | 2007-07-01 |
| NeuroModulation Technique Treatment of Autism (NCT00503191) | NeuroModulation Technique Research Institute | 2007-07-01 |
| Safety and Efficacy Study Using Rexin-G for Breast Cancer (NCT00505271) | Epeius Biotechnologies | 2007-07-01 |
| Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency). (NCT01209546) | University of Sao Paulo | 2007-07-01 |
| Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers (NCT00483353) | Pfizer | 2007-07-01 |
| Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum (NCT00448253) | Emergent BioSolutions | 2007-07-01 |
| Efficacy and Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer (NCT00426556) | Novartis Pharmaceuticals | 2007-07-01 |
| Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01026844) | Massachusetts General Hospital | 2007-07-01 |
| Cholestasis Prevention: Efficacy of IV Fish Oil (NCT00512629) | Boston Children's Hospital | 2007-07-01 |
| Bunionectomy Study (0000-063) (NCT00601458) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection (NCT00668382) | University of Massachusetts, Worcester | 2007-07-01 |
| Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease (NCT00841373) | Southern New England Retina Associates | 2007-07-01 |
| Phase I/II, Open-label, Multi-center, Two Part Dose-escalation, Safety, Pharmacokinetics (PK) and Efficacy Study of AZD4877 in Patients With Acute Myelogenous Leukemia (AML) (NCT00486265) | AstraZeneca | 2007-07-01 |
| Effects of Single Oral Dose Dapagliflozin QT Study (NCT00688493) | AstraZeneca | 2007-07-01 |
| Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension (NCT00515424) | Novartis | 2007-07-01 |
| Study of ADI-PEG 20 in Patients With Advanced Melanoma (NCT00520299) | Ludwig Institute for Cancer Research | 2007-07-01 |
| Combination of Naltrexone and Baclofen for Alcohol Dependence:A Pilot Study. (NCT00614328) | University of North Carolina, Chapel Hill | 2007-07-01 |
| Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System (NCT00497367) | Boston Scientific Corporation | 2007-07-01 |
| Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery (NCT00544362) | Federation Francophone de Cancerologie Digestive | 2007-07-01 |
| Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines (NCT00514189) | M.D. Anderson Cancer Center | 2007-07-01 |
| Autologous Dendritic Cell Vaccine in HIV1 Infection (NCT00510497) | Sharon Riddler | 2007-07-01 |
| Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma (NCT00555100) | Celgene | 2007-07-01 |
| A Novel Bio-marker of Zinc Status (NCT01062347) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2007-07-01 |
| Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck (NCT00474825) | National Baromedical Services | 2007-07-01 |
| Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders (NCT00773812) | Ohio State University | 2007-07-01 |
| Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes (NCT00641030) | City of Hope Medical Center | 2007-07-01 |
| Phase I Study of Patupilone and RAD001 (NCT00496600) | University of Medicine and Dentistry of New Jersey | 2007-07-01 |
| Defined Green Tea Catechin Extract in Treating Women With Hormone Receptor Negative Stage I-III Breast Cancer (NCT00516243) | National Cancer Institute (NCI) | 2007-07-01 |
| ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer (NCT00496665) | Dana-Farber Cancer Institute | 2007-07-01 |
| Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus (NCT00513214) | XOMA (US) LLC | 2007-07-01 |
| Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine (NCT00513968) | Genexine, Inc. | 2007-07-01 |
| Safety and Efficacy Study Using Rexin-G for Sarcoma (NCT00505713) | Epeius Biotechnologies | 2007-07-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
| A Study for Participants With Advanced Cancer (NCT01214629) | Eli Lilly and Company | 2007-07-01 |
| Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy Adults (NCT00819013) | Sanofi | 2007-07-01 |
| Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions (NCT01467687) | Synerx Pharma, LLC | 2007-07-01 |
| A Crossover Study to Assess the Effects of Vorinostat (MK0683, SAHA) in Patients With Advanced Cancer (0683-070)(COMPLETED) (NCT00632931) | Merck Sharp & Dohme LLC | 2007-07-01 |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer (NCT00429078) | Roger Williams Medical Center | 2007-07-01 |
| Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer (NCT00504998) | Epeius Biotechnologies | 2007-07-01 |
| A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men (NCT00551317) | GlaxoSmithKline | 2007-07-01 |
| Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer (NCT00510445) | Geron Corporation | 2007-07-01 |
| A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis (NCT00697710) | Shionogi | 2007-07-01 |
| Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy (NCT00497250) | Fudan University | 2007-07-01 |
| Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma (NCT02446574) | Chinese Academy of Medical Sciences | 2007-07-01 |
| Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch (NCT00791856) | Warner Chilcott | 2007-07-01 |
| Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers (NCT02259790) | Boehringer Ingelheim | 2007-07-01 |
| Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine (NCT00562237) | Solvay Pharmaceuticals | 2007-07-01 |
| Myopia Control With Simultaneous Vision Approach (NCT00919334) | The Hong Kong Polytechnic University | 2007-07-01 |
| Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects (NCT00515203) | Amgen | 2007-07-01 |
| GSK372475 Bioequivalence Study (NCT00488098) | GlaxoSmithKline | 2007-07-01 |
| Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00547443) | University of Texas Southwestern Medical Center | 2007-07-01 |